Fundraising boost for Diametrics Medical:
This article was originally published in Clinica
Executive Summary
Diametrics Medical, based in St Paul, Minnesota, has raised $1.5m through the placement of preferred stock and a five-year warrant with Mercator Advisory Group and affiliated funds. The proceeds will be used to fund the expansion of Diametrics' FDA-approved TrendCare continuous blood gas monitoring system business. The company sold its intermittent testing business to Thoratec unit International Technidyne last autumn, providing the company with much-needed funding and narrowing its business focus to continuous monitoring. Also last year, Diametrics renegotiated a distribution agreement with Philips Medical Systems, and began to set up its own direct sales force.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.